Data Overview
HydroMID® Study Analysis*
In a retrospective clinical study of 205 patients:
The HydroMID® showed a statistically significant reduction in failure rates and 6X fewer complications than standard polyurethane.
The HydroMID catheters demonstrated no DVTs versus 7% DVTs with the standard polyurethane catheters.
Taking into account all of the complication costs, the polyurethane catheters incurred an estimated $175,000+ in additional costs for complications with 7 DVTs and 22 device replacements versus the HydroMID devices.**
*Bunch, J. (2022). A Retrospective Assessment of Peripheral Catheter Failures Focusing on Catheter Composition. Journal of Infusion Nursing.
**Cost data on file at Access Vascular Inc.
HydroPICC® Study Details
In a retrospective clinical study of 121 patients:
The HydroPICC demonstrated no occlusions or replacements compared to 13 occlusions and 8 replacements with the standard polyurethane catheter.
Using HydroPICC resulted in a potential savings of up to 50% in additional material costs versus the standard polyurethane catheter highlighting the potential for time and cost savings with this device.
**Bunch, J. (2023). A retrospective, comparative, clinical study of occlusion rate of peripherally inserted central catheters fabricated of poly(vinyl alcohol)-based hydrogel composite. Journal of Materials Science: Materials Science in Medicine (2023) 34:34.
Results of a Bench Model Investigation Bacterial Adhesion
-
The purpose of this study was to compare bacterial adhesion on catheter samples using in-vitro blood flow and static models.
-
Fresh heparinized bovine blood was radiolabeled, and bacteria (Staphylococcus Aureus) was introduced.
TPU, Fluoro-modified TPU and HBM catheters were inserted into tubing segments
At the end of the flow phase, the catheters were explanted from the tubing and incubated in vials.
After the 4-hour incubation phase, the thrombus/bacteria were stripped from each catheter, processed and plated to measure the number of bacteria and thrombus present on each catheter.
A total of 12 replications was completed.
-
Conclusion
The data presented demonstrates a strong correlation between relative thrombogenicity and reduced bacterial adhesion of the HBM compared to traditional polyurethane devices.
Reduction of thrombus accumulation was evaluated using in vitro models. Pre-clinical in vitro valuations do not necessarily predict clinical performance with respect to thrombus formation.
LeRoy, K. J., & Donahue, D. T. (2023). Presented at AVA 2023 via e-poster.
Three 4 Fr PICC devices that were evaluated in the in vitro trackability and pushability test.
HydroPICC® reduced the average tracking force vs a standard polyurethane catheter by 84%.
HydroPICC reduced the average tracking force vs a thromboresistant polyurethane catheter by 90%.
Trackability Comparison
Are you interested in learning more about our products?